Health
Half of Americans not equipped to provide life-saving treatment in a crisis, poll finds
Only half the people in the U.S. feel they could be helpful in an emergency situation, a new poll found.
The Ohio State University Wexner Medical Center surveyed a national sample of 1,005 Americans, finding that only 51% of them knew how to perform hands-only CPR if needed.
In cases of serious bleeding, only 49% said they could assist, and 56% said they would be equipped to help someone who was choking.
The data was collected via phone and email from April 5 to April 7 of this year.
KIDS AS YOUNG AS 4 YEARS OLD CAN BEGIN TO LEARN MEDICAL EMERGENCY TRAINING: NEW REPORT
“The key takeaways from our survey are that patient outcomes would improve if the general public learned some basic life-saving measures in the areas of hands-only CPR, choking rescue and bleeding control,” Nicholas Kman, M.D., emergency medicine physician at Ohio State Wexner Medical Center and clinical professor of emergency medicine at The Ohio State University College of Medicine, told Fox News Digital.
“We can save lives while we wait for first responders to arrive.”
Only half the people in the U.S. feel they could be helpful in an emergency situation, a new poll has found. (iStock)
“For every minute that passes, the chance of survival drops, and if they do survive, there’s less chance of a good neurologic outcome.”
Data shows that 70% to 80% of cardiac arrests occur in the home and 20% happen in a public place, according to Kman.
HELP DESPERATELY NEEDED: AMERICAN HEART ASSOCIATION LAUNCHES ‘NATION OF LIFESAVERS’ PROGRAM
“Outcomes are poor when the arrest is unwitnessed at home,” he told Fox News Digital.
“Just think, the person with the medical emergency could be your loved one in your house. You may have to provide life-saving treatment until first responders arrive.”
Data shows that 70% to 80% of cardiac arrests occur in the home and 20% happen in a public place, a researcher said. (iStock)
Based on the survey findings, Kman advised the public to get trained in life-saving measures — particularly hands-only CPR, choking and serious bleeding.
“Look for training that may be offered through community days at hospitals, schools, libraries, community organizations, religious institutions, volunteer groups, festivals and sporting events,” he suggested.
“We’re responsible for each other.”
Organizations and websites such as the American Red Cross, the American Heart Association and Stop The Bleed may offer these courses for free or low cost, Kman noted.
After learning the skills, it’s important to practice them, the doctor said.
“We would love the public to learn how to do hands-only CPR and practice the skill of doing CPR every six weeks,” Kman said.
Based on the survey findings, researchers advised people to get trained in life-saving measures, particularly hands-only CPR, choking first-aid and serious bleeding assistance. (iStock)
“As with any skill, practice builds confidence. If we don’t practice it, we lose that skill.”
The OSU survey did have some limitations, Kman acknowledged.
“The survey was a convenience sample of a cross-section of Americans,” he told Fox News Digital.
HEART ATTACKS MORE LIKELY DURING PRESIDENTIAL ELECTIONS AND OTHER STRESSFUL TIMES, STUDY SHOWS
“Most demographics were equally represented, but different regions do better at this than others, and their cardiac arrest results and survival reflect that,” he continued.
“States and countries that prioritize training the public have higher survival rates.”
“When you’re trained in these lifesaving skills, you’ll know how to recognize the signs that someone needs help and buy time until the [first] responders can get there,” a doctor said. (iStock)
Dr. Kenneth Perry, an emergency department physician in South Carolina, was not involved in the survey but said he was surprised that more people don’t feel unprepared.
“Even for medical professionals, having a medical emergency occur without preparation can be a very stressful event,” he told Fox News Digital.
“It is very important for people to have basic lifesaving skills.”
“It is very important for people to have basic lifesaving skills.”
The easiest and most helpful skill that people should learn is how to operate an automated external defibrillator (AED). These are located in many public places, such as gyms, malls and even some public walkways, according to Perry.
“These devices are the best way to save a person who is suffering from cardiac arrest,” he said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“If the person has an abnormal heart rhythm that can be brought back to normal with electricity, this device will save that patient.”
This is a very time-sensitive process, however — it must happen as early as possible, the doctor advised.
“Early defibrillation is directly correlated with the best outcomes for patients who suffer an out-of-hospital cardiac arrest.”
Ultimately, Kwan, said, “we’re responsible for each other.”
“When you’re trained in these lifesaving skills, you’ll know how to recognize the signs that someone needs help and buy time until the responders can get there.”
For more Health articles, visit www.foxnews.com/health.
Novo Nordisk to slash Wegovy, Ozempic list prices
Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk’s decision to dramatically cut the U.S. list prices for its popular diabetes and weight-loss drugs Ozempic and Wegovy on ‘America Reports.’
NEWYou can now listen to Fox News articles!
Millions of Medicare beneficiaries struggling with obesity could soon see the cost of weight-loss drugs plummet, as a new federal pilot program launching July 1 expands access to GLP-1 medications like Wegovy and Zepbound for eligible seniors.
Through a new trial called Medicare GLP-1 Bridge, the federal government is now offering a selection of the brand-name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month, The Associated Press reported.
The covered medications include drugmaker Eli Lilly’s Foundayo tablets and Zepbound KwikPens and Novo Nordisk’s Wegovy injections and tablets, all of which have been FDA-approved for weight loss, according to the report.
OZEMPIC USERS MAY BE MAKING A MAJOR WEIGHT-LOSS MISTAKE, NEW STUDY SUGGESTS
The temporary program is set to run until the end of 2027.
This is the first time GLP-1s (glucagon-like peptide-1 receptor agonists) will be covered by insurance when used solely for weight loss.
A new federal pilot program launching July 1 expands access to GLP-1 medications like Wegovy and Zepbound for eligible seniors. (iStock)
Prior to this new Medicare pilot, seniors who wanted to access GLP-1s for obesity alone paid about $1,350-$1,650 per month for Novo Nordisk’s Wegovy (semaglutide) and about $1,086 monthly for Lilly’s Zepbound (tirzepatide). However, both manufacturers offered some cash-pay options that significantly reduced those prices for eligible patients.
GLP-1 WEIGHT LOSS DRUGS ARE RESHAPING THE BRIDAL INDUSTRY AS SHOPS RUSH ORDERS AND REQUIRE NEW WAIVERS
There are some parameters surrounding the coverage — older adults must have had a body mass index (BMI) of 35 or higher when they started GLP-1 therapy, or a BMI of 27 or higher alongside another health condition, such as a past heart attack or stroke or prediabetes.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Those who already have insurance coverage for other diseases, such as diabetes and sleep apnea, are not eligible for the program.
Through a new trial called Medicare GLP-1 Bridge, the federal government is now offering a selection of the brand-name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month. (iStock)
There are more than 70 million Americans currently enrolled in Medicare, 10 million of whom are overweight or obese, according to Juliette Cubanski, vice president and director of the program on Medicare policy at the healthcare research nonprofit KFF.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“For many older Americans living with obesity, this is a moment they and their families have been waiting for,” Jamey Millar, Novo Nordisk’s executive vice president of U.S. operations, said in a press release.
“The Medicare GLP-1 Bridge program offers a new, affordable path to an FDA-approved treatment that was previously not covered.”
CLICK HERE FOR MORE HEALTH STORIES
Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, said he hopes the program can help his agency collect data to potentially work toward longer-term coverage, while providing immediate relief to cash-strapped older Americans, AP reported.
“The sheer cost of these medications is a huge barrier to access,” he said in a call with reporters. “That ends today.”
Prior to this new Medicare pilot, seniors who wanted to access GLP-1s for obesity alone paid about $1,350-$1,650 per month for Novo Nordisk’s Wegovy (semaglutide) and about $1,086 monthly for Lilly’s Zepbound (tirzepatide). (iStock)
Oz told reporters that CMS plans to “carefully track participation and outcomes” to see whether an extension of the Bridge program or another solution is the best way to move forward. He told AP a federal law permanently allowing the coverage is “not essential right now” but something “for Congress to debate amongst themselves.”
“We can’t decide what’s going to happen long term with Bridge until we see some of the data,” he said, adding that there are ongoing talks with drug companies to lower costs.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
One potential concern is that older patients tend to have more adverse effects to medication in general , according to Dr. Micah Eimer, a clinical assistant professor of cardiology at the Northwestern University Feinberg School of Medicine.
“Specifically, in our research, older patients on blood pressure medications were more likely to experience hypotensive side effects, such as fainting and dizziness, after starting a GLP-1,” he said in a statement.
The Associated Press contributed to this report.
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
NEWYou can now listen to Fox News articles!
Federal health officials are attempting to track down the source of a microscopic parasite that triggers prolonged gastrointestinal illness, as domestic cases begin to climb for the summer season.
The Centers for Disease Control and Prevention had confirmed 145 cases of cyclosporiasis across 17 states as of mid-June 2026, all linked to infections acquired in the U.S.
The culprit is Cyclospora, a microscopic parasite known to cause cyclosporiasis.
DEADLY ‘FOX TAPEWORM’ LINKED TO LETHAL DISEASE DETECTED IN WEST COAST WILDLIFE
The hallmark symptom of the infection is watery, often “explosive” diarrhea that can last for weeks or even months if left untreated, the CDC says.
There is currently no evidence of a single, multistate Cyclospora outbreak linking all cases. (AP Photo/Jeff Amy, File)
Other symptoms include severe abdominal cramping, bloating, nausea, fatigue and significant weight loss.
The official outbreak season for the parasite runs from May 1 through Aug. 31, a window where warmer temperatures historically coincide with a spike in infections, according to the CDC.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Cases have cropped up in states ranging from Texas to Alaska. New York has been hit the hardest so far, reporting between 31 and 80 cases, followed by Texas and Illinois, which have each reported between 11 and 30 cases.
CLICK HERE FOR MORE HEALTH STORIES
While the infection can sometimes clear up on its own, it frequently requires antibiotics. Out of the 145 confirmed cases, 20 patients have required hospitalization, per the CDC.
While the infection can sometimes clear up on its own, it frequently requires antibiotics. (iStock)
No deaths have yet been reported. Patients range from 5 to 86 years old, though the median age is 42, and women make up 61% of the reported cases, data shows.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The CDC, alongside the Food and Drug Administration and state health officials, is actively investigating several multi-state clusters, but they have yet to find a cause behind the spread.
Officials urge patients with symptoms to seek help from a medical professional. (iStock)
“There is currently no evidence of a single, multistate Cyclospora outbreak linking all cases,” the CDC noted in its surveillance report.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The CDC advises anyone experiencing symptoms of cyclosporiasis to contact a healthcare provider for testing and treatment.
-
Lifestyle29 minutes agoTo be or not to be a parent : It’s Been a Minute
-
Technology41 minutes agoSony’s PlayStation disc factory is already being repurposed
-
World44 minutes agoCouple publicly caned after alleged TikTok kiss sparks outrage in Indonesia
-
Politics49 minutes agoWATCH: Controversial SCOTUS decision strikes a divide among lawmakers
-
Health56 minutes agoBig Medicare change slashes weight-loss drug costs for eligible seniors
-
Sports59 minutes agoVAR denies Croatia’s game-tying goal as Cristiano Ronaldo leads Portugal to Round of 16
-
Technology1 hour agoNew sodium-ion battery could reshape grid storage
-
Business1 hour agoHome insurer surcharges for wildfires is legal, judge rules
